Efficient Gene Delivery Tool with a Wide Therapeutic Margin

Simple SummaryContent extracted from patent full text and abstract with AI.

This invention introduces new saponin compounds, specifically modified with acetyl groups, that significantly improve gene delivery into cells while causing fewer toxic side effects than traditional saponins. These new saponins boost the efficiency of gene transfer, which is important for therapies and research relying on genetic modification.

Use CasesContent extracted from patent full text and abstract with AI.

• Gene therapy delivery systems in clinical settings
• Improvement of transfection methods in laboratory research
• Enhancing genetic modification procedures in biotechnology and pharmaceuticals
• Development of safer and more effective gene-based medicines

BenefitsContent extracted from patent full text and abstract with AI.

• Significantly higher transfection efficiency compared to existing agents
• Lower cytotoxicity, making them safer for therapeutic and research applications
• Wider therapeutic margin increases suitability for clinical use
• Potentially fewer adverse side effects for patients and experimental systems

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

The present invention relates to novel saponins according to formula (I) comprising acetyl residues on two of their sugar residues (where at least two instances of R1 and two instances of R2 represent Ac). These saponins are able to enhance the transfection efficiency to a high extent and show lower cytotoxic side-effects compared to known saponins.